Cancer and mTOR inhibitors in kidney transplantation recipients

BACKGROUND: Previous studies show that mTOR inhibitors decrease the risk of cancer development after kidney transplantation. However, the effect of cumulative doses of mTOR inhibitors on cancer after kidney transplantation is not well known. METHODS: In the current study, patients were registered in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PeerJ
Main Authors: Kao, Chih-Chin, Liu, Jia-Sin, Chang, Yu-Kang, Lin, Ming-Huang, Lin, Yen-Chung, Chen, Hsi-Hsien, Chang, Wei-Chiao, Hsu, Chih-Cheng, Wu, Mai-Szu
Formato: Artigo
Idioma:Inglês
Publicado em: PeerJ Inc. 2018
Assuntos:
Internal Medicine
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6237112/
https://ncbi.nlm.nih.gov/pubmed/30473931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7717/peerj.5864
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados